FutureBiotics, Cholesta-Lo With Garlic & Niacin, 120 Tablets
- ₴1303
- Наявність:Є в наявності
- Виробник: FutureBiotics (Фьючербайотикс)
- Код товару: FBS-00169
Cholesta-Lo is comprehensive formula that provides nutrients and other key factors to nutritionally support healthy cholesterol levels within the normal range. Along with plant sterols and flush-free niacin, it includes Resveratrol, which research suggests may play a role in supporting cardiovascular health. It is also potency enhanced with Futurebiotics exclusive BioAccelerators including Lactospore probiotics, for improve nutrient absorption and utilization.
Рекомендации по применениюAs a dietary supplement for adults, take 3 tablets daily or as directed by a healthcare professional.
Другие ингредиентыMicrocrystalline cellulose, croscarmellose sodium, stearic acid, vegetable stearate, silica, hydroxypropyl methylcellulose, polyethylene glycol.
Contains soy.
Contains no added yeast, starch, sugar, salt, wheat, gluten, dairy, artificial colors, preservatives or animal products.
ПредупрежденияDo not use if you are pregnant or nursing.
Keep out of reach of children.
As a dietary supplement for adults, take 3 tablets daily or as directed by a healthcare professional.
| Информация о Добавках | ||
| Serving Size: 3 Tablets | ||
| Servings Per Container: 40 | ||
| Amount Per Serving | %Daily Value | |
| Niacin (as flush-free inositol hexanicotinate) | 200 mg | 1000% |
| Chromium (as chromium polynicotinate) | 100 mcg | 83% |
| Plant Sterols (providing Beta-Sitosterol, Campesterol and Stigmasterol) | 600 mg | † |
| Garlic bulb | 350 mg | † |
| Parsley bulb | 250 mg | † |
| Chickweed herb | 250 mg | † |
| Ginger root | 200 mg | † |
| Cayenne fruit | 50 mg | † |
| Hawthorn berries | 150 mg | † |
| Eleuthero rhizome extract | 75 mg | † |
| Polygonum cuspidatum root extract (standardized for 50% (10 mg) Resveratrol) | 20 mg | † |
| Futurebiotics BioAccelerators: Bioperine, Ginger root extract, Trikatu, Digezyme, Lactospore | 23 mg | † |
| †Daily Value not established. | ||
